The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationCalcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., et al. (1997) · Nature · doi:10.1038/40187 · Cited by 2,859
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationA Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Self-citationExpression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H.-A., Jansa, P., Jing, Z.-C., Le Brun, F.-O., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,443
Self-citationSIMONNEAU, G., BARST, R. J., GALIE, N., NAEIJE, R., RICH, S., BOURGE, R. C., KEOGH, A., OUDIZ, R., FROST, A., BLACKBURN, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,441
Self-citationRiociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H.-A., D'Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,401
Self-citationHumbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Self-citationGiaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346
Self-citationLong-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Self-citationChristman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Pulmonary Arterial Hypertension
Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A. E., Barst, R. J., Benza, R. L., Liou, T. G., Turner, M., et al. (2010) · Chest · doi:10.1378/chest.09-1140 · Cited by 1,178
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Kerkelä, R., Grazette, L., Yacobi, R., Iliescu, C., Patten, R., Beahm, C., Walters, B., Shevtsov, S., Pesant, S., Clubb, F. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1446 · Cited by 1,159
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
Self-citationGaliè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,083
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Primary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V, Steele, P. M., Edwards, W. D., Gersh, B. J., McGoon, M. D., & Frye, R. L. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,066
Galiè, N., Rubin, L., Hoeper, M., Jansa, P., Al-Hiti, H., Meyer, G., Chiossi, E., Kusic-Pajic, A., & Simonneau, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60919-8 · Cited by 920
Self-citationGaliè, N., Beghetti, M., Gatzoulis, M. A., Granton, J., Berger, R. M. F., Lauer, A., Chiossi, E., & Landzberg, M. (2006) · Circulation · doi:10.1161/circulationaha.106.630715 · Cited by 843
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Coghlan, J. G., Denton, C. P., Grünig, E., Bonderman, D., Distler, O., Khanna, D., Müller-Ladner, U., Pope, J. E., Vonk, M. C., Doelberg, M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203301 · Cited by 832
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Self-citationAn epidemiological study of pulmonary arterial hypertension
Peacock, A. J., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 792
Enzyme-independent formation of nitric oxide in biological tissues
Zweier, J. L., Wang, P., Samouilov, A., & Kuppusamy, P. (1995) · Nature Medicine · doi:10.1038/nm0895-804 · Cited by 788
Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression
Hardingham, G. E., Chawla, S., Johnson, C. M., & Bading, H. (1997) · Nature · doi:10.1038/385260a0 · Cited by 729
Atkinson, C., Stewart, S., Upton, P. D., Machado, R., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 697
Modern Age Pathology of Pulmonary Arterial Hypertension
Stacher, E., Graham, B. B., Hunt, J. M., Gandjeva, A., Groshong, S. D., McLaughlin, V. V., Jessup, M., Grizzle, W. E., Aldred, M. A., Cool, C. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0164oc · Cited by 667
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
Galiè, N., Corris, P. A., Frost, A., Girgis, R. E., Granton, J., Jing, Z. C., Klepetko, W., McGoon, M. D., McLaughlin, V. V., Preston, I. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.031 · Cited by 667
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Self-citationConnective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Galiè, N., Humbert, M., Vachiéry, J.-L., Vizza, C., Kneussl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 648
Self-citationCombination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 640
Self-citationBeraprost therapy for pulmonary arterial hypertension
Barst, R. J., McGoon, M., McLaughlin, V., Tapson, V., Oudiz, R., Shapiro, S., Robbins, I. M., Channick, R., Badesch, D., Rayburn, B. K., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00463-7 · Cited by 631
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 626
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R., Grünig, E., Aldred, M., Geraci, M., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 616
Self-citationSimonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 616
Self-citationSoluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Self-citationHoeper, M. M., Barst, R. J., Bourge, R. C., Feldman, J., Frost, A. E., Galié, N., Gómez-Sánchez, M. A., Grimminger, F., Grünig, E., Hassoun, P. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000765 · Cited by 574
Self-citationHirata, Y., Emori, T., Eguchi, S., Kanno, K., Imai, T., Ohta, K., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116338 · Cited by 568
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
McLaughlin, V. V., Benza, R. L., Rubin, L. J., Channick, R. N., Voswinckel, R., Tapson, V. F., Robbins, I. M., Olschewski, H., Rubenfire, M., & Seeger, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.027 · Cited by 566
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560
Self-citationNO-independent regulatory site on soluble guanylate cyclase
Stasch, J.-P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Minuth, T., Perzborn, E., Pleiß, U., et al. (2001) · Nature · doi:10.1038/35065611 · Cited by 545
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
Rybalkin, S. D., Yan, C., Bornfeldt, K. E., & Beavo, J. A. (2003) · Circulation Research · doi:10.1161/01.res.0000087541.15600.2b · Cited by 511
Archer, S. L., Weir, E. K., & Wilkins, M. R. (2010) · Circulation · doi:10.1161/circulationaha.108.847707 · Cited by 485
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
A Novel Channelopathy in Pulmonary Arterial Hypertension
Ma, L., Roman-Campos, D., Austin, E. D., Eyries, M., Sampson, K. S., Soubrier, F., Germain, M., Trégouët, D.-A., Borczuk, A., Rosenzweig, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211097 · Cited by 477
Self-citationPlatelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Montani, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1037oc · Cited by 472
Self-citationGoal-oriented treatment and combination therapy for pulmonary arterial hypertension
Hoeper, M. M., Markevych, I., Spiekerkoetter, E., Welte, T., & Niedermeyer, J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00075305 · Cited by 468
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Spiekerkoetter, E., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., Li, C. G., El-Bizri, N., Sawada, H., Haghighat, R., Chan, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65592 · Cited by 449
Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
Velez-Roa, S., Ciarka, A., Najem, B., Vachiery, J.-L., Naeije, R., & van de Borne, P. (2004) · Circulation · doi:10.1161/01.cir.0000140724.90898.d3 · Cited by 443
Pathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Lee, S. D., Shroyer, K. R., Markham, N. E., Cool, C. D., Voelkel, N. F., & Tuder, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1910 · Cited by 428
Yuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S. P., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 425
Inflammation in Pulmonary Arterial Hypertension
Price, L. C., Wort, S. J., Perros, F., Dorfmüller, P., Huertas, A., Montani, D., Cohen-Kaminsky, S., & Humbert, M. (2012) · Chest · doi:10.1378/chest.11-0793 · Cited by 403
Self-citationMutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., et al. (2006) · Human Mutation · doi:10.1002/humu.20285 · Cited by 402
Self-citationJais, X., Launay, D., Yaici, A., Le Pavec, J., Tchérakian, C., Sitbon, O., Simonneau, G., & Humbert, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 398
Self-citationImatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Ghofrani, H. A., Morrell, N. W., Hoeper, M. M., Olschewski, H., Peacock, A. J., Barst, R. J., Shapiro, S., Golpon, H., Toshner, M., Grimminger, F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0123oc · Cited by 384
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382
Self-citationHumbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30541 · Cited by 379
Self-citationMechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Chen, M. H., Kerkelä, R., & Force, T. (2008) · Circulation · doi:10.1161/circulationaha.108.776831 · Cited by 379
Tapson, V. F., Torres, F., Kermeen, F., Keogh, A. M., Allen, R. P., Frantz, R. P., Badesch, D. B., Frost, A. E., Shapiro, S. M., Laliberte, K., et al. (2012) · Chest · doi:10.1378/chest.11-2212 · Cited by 378
Olsson, K. M., Delcroix, M., Ghofrani, H. A., Tiede, H., Huscher, D., Speich, R., Grünig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 372
Genetics and Genomics of Pulmonary Arterial Hypertension
Machado, R. D., Eickelberg, O., Elliott, C. G., Geraci, M. W., Hanaoka, M., Loyd, J. E., Newman, J. H., Phillips, J. A., Soubrier, F., Trembath, R. C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.015 · Cited by 372
Michelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32503 · Cited by 367
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Self-citationGraded balloon dilation atrial septostomy in severe primary pulmonary hypertension
Sandoval, J., Gaspar, J., Pulido, T., Bautista, E., Martínez-Guerra, M. L., Zeballos, M., Palomar, A., & Gómez, A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00238-1 · Cited by 356
Golovina, V. A., Platoshyn, O., Bailey, C. L., Wang, J., Limsuwan, A., Sweeney, M., Rubin, L. J., & Yuan, J. X.-J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h746 · Cited by 352
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0411oc · Cited by 346
Self-citationDorfmüller, P., Humbert, M., Perros, F., Sanchez, O., Simonneau, G., Müller, K.-M., & Capron, F. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.022 · Cited by 341
Self-citationTeichert-Kuliszewska, K., Kutryk, M. J. B., Kuliszewski, M. A., Karoubi, G., Courtman, D. W., Zucco, L., Granton, J., & Stewart, D. J. (2006) · Circulation Research · doi:10.1161/01.res.0000200180.01710.e6 · Cited by 331
Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
Iglarz, M., Binkert, C., Morrison, K., Fischli, W., Gatfield, J., Treiber, A., Weller, T., Bolli, M. H., Boss, C., Buchmann, S., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142976 · Cited by 329
Jing, Z.-C., Parikh, K., Pulido, T., Jerjes-Sanchez, C., White, R. J., Allen, R., Torbicki, A., Xu, K.-F., Yehle, D., Laliberte, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.124388 · Cited by 326
Wang, X.-X., Zhang, F.-R., Shang, Y.-P., Zhu, J.-H., Xie, X.-D., Tao, Q.-M., Zhu, J.-H., & Chen, J.-Z. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.037 · Cited by 322
Simonneau, G., Torbicki, A., Hoeper, M. M., Delcroix, M., Karlócai, K., Galiè, N., Degano, B., Bonderman, D., Kurzyna, M., Efficace, M., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00137511 · Cited by 314
Self-citationET A and ET B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells
DAVIE, N., HALEEN, S. J., UPTON, P. D., POLAK, J. M., YACOUB, M. H., MORRELL, N. W., & WHARTON, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2104059 · Cited by 314
Provencher, S., Herve, P., Jais, X., Lebrec, D., Humbert, M., Simonneau, G., & Sitbon, O. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.013 · Cited by 312
Self-citationPulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 308
Self-citationEddahibi, S., Guignabert, C., Barlier-Mur, A.-M., Dewachter, L., Fadel, E., Dartevelle, P., Humbert, M., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 297
Self-citationTapson, V. F., Jing, Z.-C., Xu, K.-F., Pan, L., Feldman, J., Kiely, D. G., Kotlyar, E., McSwain, C. S., Laliberte, K., Arneson, C., et al. (2013) · Chest · doi:10.1378/chest.12-2875 · Cited by 297
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
Humbert, M., Segal, E. S., Kiely, D. G., Carlsen, J., Schwierin, B., & Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00138706 · Cited by 295
Self-citationTreatment Goals of Pulmonary Hypertension
McLaughlin, V. V., Gaine, S. P., Howard, L. S., Leuchte, H. H., Mathier, M. A., Mehta, S., Palazzini, M., Park, M. H., Tapson, V. F., & Sitbon, O. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.034 · Cited by 294
Self-citationChemokine RANTES in Severe Pulmonary Arterial Hypertension
DORFMÜLLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINÉ, A., MARFAING-KOKA, A., SIMONNEAU, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Self-citationCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H., Halank, M., Wilkens, H., Meyer, F. J., Seyfarth, H. J., Wensel, R., Ripken, F., Bremer, H., Kluge, S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 288
Bogaard, H. J., Natarajan, R., Mizuno, S., Abbate, A., Chang, P. J., Chau, V. Q., Hoke, N. N., Kraskauskas, D., Kasper, M., Salloum, F. N., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0335oc · Cited by 287
Fukumoto, Y., Matoba, T., Ito, A., Tanaka, H., Kishi, T., Hayashidani, S., Abe, K., Takeshita, A., & Shimokawa, H. (2005) · Heart · doi:10.1136/hrt.2003.029470 · Cited by 286
Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator
Hunter, C. J., Dejam, A., Blood, A. B., Shields, H., Kim-Shapiro, D. B., Machado, R. F., Tarekegn, S., Mulla, N., Hopper, A. O., Schechter, A. N., et al. (2004) · Nature Medicine · doi:10.1038/nm1109 · Cited by 281
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Jaïs, X., Olsson, K. M., Barbera, J. A., Blanco, I., Torbicki, A., Peacock, A., Vizza, C. D., Macdonald, P., Humbert, M., & Hoeper, M. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00141211 · Cited by 268
Self-citationCharacterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells
Wielinga, P. R., van der Heijden, I., Reid, G., Beijnen, J. H., Wijnholds, J., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212723200 · Cited by 266
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Fleming, T. R., Galiè, N., Simonneau, G., Ghofrani, H. A., Oakes, M., Layton, G., Serdarevic-Pehar, M., McLaughlin, V. V., et al. (2011) · Chest · doi:10.1378/chest.10-0969 · Cited by 259
Self-citationAlastalo, T.-P., Li, M., de Jesus Perez, V., Pham, D., Sawada, H., Wang, J. K., Koskenvuo, M., Wang, L., Freeman, B. A., Chang, H. Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43382 · Cited by 254
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1
Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01256.x · Cited by 243
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension
Chen, S.-L., Zhang, F.-F., Xu, J., Xie, D.-J., Zhou, L., Nguyen, T., & Stone, G. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.075 · Cited by 234
Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells
Olschewski, A., Li, Y., Tang, B., Hanze, J., Eul, B., Bohle, R. M., Wilhelm, J., Morty, R. E., Brau, M. E., Weir, E. K., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000219677.12988.e9 · Cited by 232
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension
de Man, F. S., Handoko, M. L., Groepenhoff, H., van 't Hul, A. J., Abbink, J., Koppers, R. J. H., Grotjohan, H. P., Twisk, J. W. R., Bogaard, H.-J., Boonstra, A., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00027909 · Cited by 232
Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension
Toshner, M., Voswinckel, R., Southwood, M., Al-Lamki, R., Howard, L. S. G., Marchesan, D., Yang, J., Suntharalingam, J., Soon, E., Exley, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1662oc · Cited by 229
Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
Sanchez, O., Marcos, E., Perros, F., Fadel, E., Tu, L., Humbert, M., Dartevelle, P., Simonneau, G., Adnot, S., & Eddahibi, S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1559oc · Cited by 228
Self-citationDiller, G.-P., van Eijl, S., Okonko, D. O., Howard, L. S., Ali, O., Thum, T., Wort, S. J., Bédard, E., Gibbs, J. S. R., Bauersachs, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769646 · Cited by 224
Chan, L., Chin, L. M. K., Kennedy, M., Woolstenhulme, J. G., Nathan, S. D., Weinstein, A. A., Connors, G., Weir, N. A., Drinkard, B., Lamberti, J., et al. (2013) · Chest · doi:10.1378/chest.12-0993 · Cited by 217
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Guignabert, C., Tu, L., Le Hiress, M., Ricard, N., Sattler, C., Seferian, A., Huertas, A., Humbert, M., & Montani, D. (2013) · European Respiratory Review · doi:10.1183/09059180.00007513 · Cited by 206
Self-citationBisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension
de Man, F. S., Handoko, M. L., van Ballegoij, J. J. M., Schalij, I., Bogaards, S. J. P., Postmus, P. E., van der Velden, J., Westerhof, N., Paulus, W. J., & Vonk-Noordegraaf, A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.964494 · Cited by 204
Atrial flutter and fibrillation in patients with pulmonary hypertension
Olsson, K. M., Nickel, N. P., Tongers, J., & Hoeper, M. M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.024 · Cited by 204
Maron, B. A., Zhang, Y.-Y., White, K., Chan, S. Y., Handy, D. E., Mahoney, C. E., Loscalzo, J., & Leopold, J. A. (2012) · Circulation · doi:10.1161/circulationaha.112.094722 · Cited by 200
Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension
Mainguy, V., Maltais, F., Saey, D., Gagnon, P., Martel, S., Simon, M., & Provencher, S. (2010) · Thorax · doi:10.1136/thx.2009.117168 · Cited by 188
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension
Reynolds, A. M., Holmes, M. D., Danilov, S. M., & Reynolds, P. N. (2012) · European Respiratory Journal · doi:10.1183/09031936.00187310 · Cited by 186
New mechanisms of pulmonary arterial hypertension: role of Ca2+signaling
Kuhr, F. K., Smith, K. A., Song, M. Y., Levitan, I., & Yuan, J. X.-J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00944.2011 · Cited by 185
Two-Pore Domain K Channel, TASK-1, in Pulmonary Artery Smooth Muscle Cells
Gurney, A. M., Osipenko, O. N., MacMillan, D., McFarlane, K. M., Tate, R. J., & Kempsill, F. E. J. (2003) · Circulation Research · doi:10.1161/01.res.0000099883.68414.61 · Cited by 183
Kanki-Horimoto, S., Horimoto, H., Mieno, S., Kishida, K., Watanabe, F., Furuya, E., & Katsumata, T. (2006) · Circulation · doi:10.1161/circulationaha.105.001487 · Cited by 174
Tamby, M. C. (2005) · Thorax · doi:10.1136/thx.2004.029082 · Cited by 174
Grünig, E., Ehlken, N., Ghofrani, A., Staehler, G., Meyer, F. J., Juenger, J., Opitz, C. F., Klose, H., Wilkens, H., Rosenkranz, S., et al. (2011) · Respiration · doi:10.1159/000322475 · Cited by 173
Tu, L., Dewachter, L., Gore, B., Fadel, É., Dartevelle, P., Simonneau, G., Humbert, M. J. C., Eddahibi, S., & Guignabert, C. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0317oc · Cited by 173
Self-citationRhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling
Guilluy, C., Eddahibi, S., Agard, C., Guignabert, C., Izikki, M., Tu, L., Savale, L., Humbert, M., Fadel, E., Adnot, S., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-691oc · Cited by 172
Self-citationKurzyna, M., Dąbrowski, M., Bielecki, D., Fijalkowska, A., Pruszczyk, P., Opolski, G., Burakowski, J., Florczyk, M., Tomkowski, W. Z., Wawrzyńska, L., et al. (2007) · Chest · doi:10.1378/chest.06-1227 · Cited by 160
Fadel, E., Mercier, O., Mussot, S., Leroy-Ladurie, F., Cerrina, J., Chapelier, A., Simonneau, G., & Dartevelle, P. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.02.039 · Cited by 159
Self-citationDirect activation of PDE5 by cGMP
Müllershausen, F., Friebe, A., Feil, R., Thompson, W. J., Hofmann, F. B., & Koesling, D. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211041 · Cited by 156
Fukumoto, Y., Yamada, N., Matsubara, H., Mizoguchi, M., Uchino, K., Yao, A., Kihara, Y., Kawano, M., Watanabe, H., Takeda, Y., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0443 · Cited by 156
Brock, M., Samillan, V. J., Trenkmann, M., Schwarzwald, C. C., Ulrich, S., Gay, R. E., Gassmann, M., Østergaard, L., Gay, S., Speich, R., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs060 · Cited by 152
Zhao, L., Ashek, A., Wang, L., Fang, W., Dabral, S., Dubois, O., Cupitt, J., Pullamsetti, S. S., Cotroneo, E., Jones, H. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004136 · Cited by 142
Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension
Kawut, S. M., Bagiella, E., Lederer, D. J., Shimbo, D., Horn, E. M., Roberts, K. E., Hill, N. S., Barr, R. G., Rosenzweig, E. B., Post, W. S., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015693 · Cited by 140
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
Tamby, M. C., Humbert, M. J. C., Guilpain, P., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00152705 · Cited by 136
Self-citationSimvastatin as a Treatment for Pulmonary Hypertension Trial
Wilkins, M. R., Ali, O., Bradlow, W. M., Wharton, J., Taegtmeyer, A., Rhodes, C. J., Ghofrani, H. A., Howard, L., Nihoyannopoulos, P., Mohiaddin, R. H., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009111-699oc · Cited by 134
New Trial Designs and Potential Therapies for Pulmonary Artery Hypertension
Gomberg‐Maitland, M., Bull, T. M., Saggar, R., Barst, R. J., Elgazayerly, A., Fleming, T. R., Grimminger, F., Rainisio, M., Stewart, D. J., Stockbridge, N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.026 · Cited by 134
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
Grünig, E., Maier, F., Ehlken, N., Fischer, C., Lichtblau, M., Blank, N., Fiehn, C., Stöckl, F., Prange, F., Staehler, G., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3883 · Cited by 128
Morecroft, I., Dempsie, Y., Bäder, M., Walther, D. J., Kotnik, K., Loughlin, L., Nilsen, M., & MacLean, M. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000252210.58849.78 · Cited by 128
Esch, J. J., Shah, P. B., Cockrill, B. A., Farber, H. W., Landzberg, M. J., Mehra, M. R., Mullen, M. P., Opotowsky, A. R., Waxman, A. B., Lock, J. E., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.01.1049 · Cited by 126
Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary Hypertension
Murata, T., Kinoshita, K., Hori, M., Kuwahara, M., Tsubone, H., Karaki, H., & Ozaki, H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186184.33537.48 · Cited by 123
Therapeutic Efficacy of AAV1.SERCA2a in Monocrotaline-Induced Pulmonary Arterial Hypertension
Hadri, L., Kratlian, R. G., Bénard, L., Maron, B. A., Dorfmüller, P., Ladage, D., Guignabert, C., Ishikawa, K., Agüero, J., Ibáñez, B., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001585 · Cited by 123
Self-citationDoran, A. K., Ivy, D. D., Barst, R. J., Hill, N., Murali, S., & Benza, R. L. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01811.x · Cited by 118
Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice
Hara, Y., Sassi, Y., Guibert, C., Gambaryan, N., Dorfmüller, P., Eddahibi, S., Lompré, A., Humbert, M. J. C., & Hulot, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45023 · Cited by 116
Self-citationSleep-Related Breathing Disorders in Patients With Pulmonary Hypertension
Ulrich, S., Fischler, M., Speich, R., & Bloch, K. E. (2008) · CHEST Journal · doi:10.1378/chest.07-3035 · Cited by 112
Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension
Drake, K. M., Dunmore, B. J., McNelly, L. N., Morrell, N. W., & Aldred, M. A. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0100oc · Cited by 112
Pulmonary hypertension: therapeutic targets within the serotonin system
Dempsie, Y., & MacLean, M. R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.241 · Cited by 111
Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries
Nagaraj, C., Tang, B., Bálint, Z., Wygrecka, M., Hrzenjak, A., Kwapiszewska, G., Stacher, E., Lindenmann, J., Weir, Ε. K., Olschewski, H., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00211811 · Cited by 107
Zuckerbraun, B. S., George, M. P., & Gladwin, M. T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq370 · Cited by 106
Pulmonary hypertension associated with benfluorex exposure
Savale, L., Chaumais, M., Cottin, V., Bergot, E., Frachon, I., Prévôt, G., Pison, C. M., Dromer, C., Poubeau, P., Lamblin, N., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00188611 · Cited by 103
Self-citationGirerd, B., Montani, D., Eyries, M., Yaïci, A., Sztrymf, B., Coulet, F., Sitbon, O., Simonneau, G., Soubrier, F., & Humbert, M. J. C. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-73 · Cited by 97
Self-citationNocturnal periodic breathing in primary pulmonary hypertension
Schulz, R., Baseler, G., Ghofrani, H. A., Grimminger, F., Olschewski, H., & Seeger, W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00225102 · Cited by 94
Arcot, S. S., Lipke, D. W., Gillespie, M. N., & Olson, J. W. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90675-m · Cited by 93
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Smadja, D. M., Mauge, L., Sanchez, O., Silvestre, J., Guérin, C. L., Godiér, A., Henno, P., Gaussem, P., & Israël‐Biet, D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00130809 · Cited by 91
Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase
Schmidt, P. M., Schramm, M., Schröder, H., & Stasch, J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01674-1 · Cited by 90
Song, M., Makino, A., & Yuan, J. X. ‐. (2011) · Pulmonary Circulation · doi:10.4103/2045-8932.78106 · Cited by 89
Sitbon, O., Manes, A., Jaïs, X., Pallazini, M., Humbert, M. J. C., Presotto, L., de Paillette, L., Zaccardelli, D., Davis, G., Jeffs, R., et al. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31802b3184 · Cited by 88
Self-citationUlrich, S., Keusch, S., Hildenbrand, F. F., Cascio, C. M. L., Huber, L. C., Tanner, F. C., Speich, R., & Bloch, K. E. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.1093/eurheartj/eht540 · Cited by 83
Apelin-APJ Signaling: a Potential Therapeutic Target for Pulmonary Arterial Hypertension
Kim, J. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2308 · Cited by 77
Sitbon, O., Delcroix, M., Bergot, E., Boonstra, A., Granton, J. T., Langleben, D., Subías, P. E., Galiè, N., Pfister, T., Lemarié, J., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.08.007 · Cited by 71
Self-citationMajor bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension
Henkens, I. R., Hazenoot, T., Boonstra, A., Huisman, M. V., & Noordegraaf, A. V. (2012) · European Respiratory Journal · doi:10.1183/09031936.00039212 · Cited by 68
Effects of Telmisartan on Right Ventricular Remodeling Induced by Monocrotaline in Rats
Okada, M., Harada, T., Kikuzuki, R., Yamawaki, H., & Hara, Y. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09112fp · Cited by 67
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Lavelle, A., Sugrue, R., Lawler, G. S., Mulligan, N. J., Kelleher, B., Murphy, D. M., & Gaine, S. (2009) · European Respiratory Journal · doi:10.1183/09031936.00058409 · Cited by 63
Cellular pathophysiology and therapy of pulmonary hypertension
Olschewski, H., Rose, F., Grünig, E., Ghofrani, H. A., WALMRATH, D., Schulz, R., SCHERMULY, R. T., Grimminger, F., & Seeger, W. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.119285 · Cited by 62
Rich, J. D., Glassner, C., Wade, M., Coslet, S., Arneson, C. P., Doran, A. K., & Gomberg‐Maitland, M. (2011) · CHEST Journal · doi:10.1378/chest.11-0245 · Cited by 58
Kanki, S., Horimoto, H., Mieno, S., Kishida, K., Watanabe, F., Furuya, E., & Katsumata, T. (2006) · Circulation · doi:10.1161/circulationaha.105.001586 · Cited by 57
Rouleau, J. L., Kapuku, G. K., Pelletier, S. W., Gosselin, H., Adam, A. A., Gagnon, C., Lambert, C., & Meloche, S. (2001) · Circulation · doi:10.1161/hc3401.093149 · Cited by 56
Simvastatin enhances bone morphogenetic protein receptor type II expression
Hu, H., Sung, A. W., Zhao, G., Shi, L., Qiu, D., Nishimura, T., & Kao, P. N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.187 · Cited by 54
Sitbon, O., & Galiè, N. (2010) · European Respiratory Review · doi:10.1183/09059180.00008210 · Cited by 50
Self-citationKummer, O., Haschke, M., Hammann, F., Bodmer, M., Bruderer, S., Regnault, Y., Dingemanse, J., & Krähenbühl, S. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.09.005 · Cited by 40
Ghofrani, H. A., Al‐Hiti, H., Noordegraaf, A. V., Behr, J., Neurohr, C., Jansa, P., Wilkens, H., Hoeper, M. M., Grünig, E., Opitz, C. F., et al. (2012) · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2496 · Cited by 38
Humbert, M. J. C. (2013) · Circulation · doi:10.1161/circulationaha.113.001460 · Cited by 31
Self-citationDandel, M., Lehmkuhl, H. B., Mulahasanovic, S., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.012 · Cited by 25
Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension
Yang, J.-X., Pan, Y.-Y., Zhao, Y., & Wang, X.-X. (2013) · Cell Transplantation · doi:10.3727/096368912x659899 · Cited by 24
Statin-Mediated Inhibition of Rho
Brandes, R. P. (2005) · Circulation Research · doi:10.1161/01.res.0000168040.70096.2a · Cited by 20
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension
Preston, I. R., Suissa, S., & Humbert, M. J. C. (2013) · European Respiratory Review · doi:10.1183/09059180.00006413 · Cited by 15
Self-citationPulmonary Hypertension: Pathology
Dorfmüller, P. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-45805-1_3 · Cited by 11
Cited by
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Self-citationPulmonary Arterial Hypertension
Hassoun, P. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2000348 · Cited by 693
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Humbert, M., McLaughlin, V., Gibbs, J. S. R., Gomberg-Maitland, M., Hoeper, M. M., Preston, I. R., Souza, R., Waxman, A., Escribano Subias, P., Feldman, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024277 · Cited by 608
Self-citationPulmonary veno-occlusive disease
Montani, D., Lau, E. M., Dorfmüller, P., Girerd, B., Jaïs, X., Savale, L., Perros, F., Nossent, E., Garcia, G., Parent, F., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00026-2016 · Cited by 517
Self-citation
Metadata
- Authors
- Humbert, M., Lau, E. M. T., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G.
- Venue
- Circulation
- Published
- 2014-12
- Volume
- 130
- Issue
- 24
- Pages
- 2189-2208
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2124275351
- Cited by
- 342
- References
- 177
- FWCI
- 24.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.